https://investor.ironwoodpharma.com/press-releases/press-release-details/2019/Ironwood-Pharmaceuticals-Reports-First-Quarter-2019-Results-Announces-Positive-2019-Adjusted-EBITDA-from-Continuing-Operations-Guidance/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- May 2, 2019